|Bid||2.6400 x 1200|
|Ask||2.6500 x 1300|
|Day's Range||2.5722 - 2.6850|
|52 Week Range||1.4400 - 4.7500|
|Beta (5Y Monthly)||-1.81|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The big shareholder groups in vTv Therapeutics Inc. ( NASDAQ:VTVT ) have power over the company. Large companies...
vTv Therapeutics (VTVT) delivered earnings and revenue surprises of -50.00% and 23.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
The FDA bestows a Breakthrough Therapy designation to vTv Therapeutics' (VTVT) TTP399 as an adjunctive therapy to insulin for treating type I diabetes. Shares rise.